BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16728937)

  • 1. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet function testing in cardiovascular diseases.
    Michelson AD
    Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin resistance: myth or major problem?
    Grove EL; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(4):257-9. PubMed ID: 18612918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders.
    Manoharan A; Gemmell R; Hartwell T
    Am J Hematol; 2006 Sep; 81(9):676-83. PubMed ID: 16795055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical importance of antiplatelet drugs in cardiovascular diseases.
    Papp J; Kenyeres P; Toth K
    Clin Hemorheol Microcirc; 2013; 53(1-2):81-96. PubMed ID: 22954637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental management of patients taking antiplatelet medications.
    Henry RG
    Tex Dent J; 2009 Jul; 126(7):608-16. PubMed ID: 19753816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 14. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin resistance: what, why and when?
    Shantsila E; Watson T; Lip GY
    Thromb Res; 2007; 119(5):551-4. PubMed ID: 17010411
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and acquired determinants of individual variability of response to antiplatelet drugs.
    Schafer AI
    Circulation; 2003 Aug; 108(8):910-1. PubMed ID: 12939239
    [No Abstract]   [Full Text] [Related]  

  • 17. Clopidogrel resistance?
    Gurbel PA; Tantry US
    Thromb Res; 2007; 120(3):311-21. PubMed ID: 17109936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 19. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.